Heribert Schunkert

Ten-year clinical outcomes of drug-eluting stents with different polymer coating strategies by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials

Rheude T, Koch T, Joner M, Lenz T, Xhepa E, Wiebe J, Coughlan J, Aytekin A, Cassese S, Laugwitz K, Schunkert H, Kastrati A, Kufner S

February 20, 2023 | 10.4244/EIJ-D-22-00781

Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis

Coughlan J, Aytekin A, Lahu S, Scalamogna M, Wiebe J, Pinieck S, Kufner S, Xhepa E, Joner M, Kuna C, Voll F, Laugwitz K, Schunkert H, Kastrati A, Cassese S

February 8, 2023 | 10.4244/EIJ-D-22-00860

Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial

Wiebe J, Byrne R, Alfonso F, Maeng M, Bradaric C, Kretov E, Cuesta J, Kuna C, Ibrahim T, Rivero F, Heugl M, Christiansen E, Joner M, Schunkert H, Laugwitz K, Kastrati A, Cassese S

March 18, 2022 | 10.4244/EIJ-D-21-00653

Transcatheter valve repair in congenitally corrected transposition of the great arteries

Ott I, Rumpf P, Kasel AM, Kastrati A, Kaemmerer H, Schunkert H, Ewert P, Tutarel O

October 20, 2021 | 10.4244/EIJ-D-20-01093

Clinical and angiographic outcomes of crossing techniques for coronary chronic total occlusions: the ISAR-CTO registry

Xhepa E, Cassese S, Ndrepepa G, Joner M, Kufner S, Aytekin A, Lahmann A, Voll F, Fusaro M, Pinieck S, Schunkert H, Kastrati A, Fusaro M

October 1, 2021 | 10.4244/EIJ-D-20-01248

Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis

Xhepa E, Bresha J, Joner M, Hapfelmeier A, Rivero F, Ndrepepa G, Nano N, Cuesta J, Kufner S, Cassese S, Bastante T, Aytekin A, Rroku A, García-Guimaraes M, Lahmann A, Pinieck S, Rai H, Fusaro M, Schunkert H, Pérez-Vizcayno M, Gonzalo N, Alfonso F, Kastrati A

August 6, 2021 | 10.4244/EIJ-D-20-00662

Predictors of haemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves

Rheude T, Pellegrini C, Cassese S, Wiebe J, Wagner S, Trenkwalder T, Alvarez H, Mayr P, Hengstenberg C, Schunkert H, Kastrati A, Husser O, Joner M

February 20, 2020 | 10.4244/EIJ-D-19-00710

Enhanced platelet inhibition by clopidogrel and risk of bleeding in patients requiring oral anticoagulation after drug-eluting stent implantation

Goedel A, Fiedler K, Mehilli J, Bernlochner I, von Olshausen G, Mayer K, Schüpke S, Hoppmann P, Sibbing D, Maeng M, Massberg S, Schunkert H, Laugwitz K, Kastrati A, Sarafoff N

October 18, 2019 | 10.4244/EIJ-D-18-00995

Sex and long-term outcomes after implantation of the Absorb bioresorbable vascular scaffold for treatment of coronary artery disease

Baquet M, Hoppmann P, Grundmann D, Schmidt W, Kufner S, Theiss H, Brunner S, Wiebe J, Eickhoff M, Jochheim D, Byrne R, Laugwitz K, Schunkert H, Massberg S, Kastrati A, Mehilli J

September 20, 2019 | 10.4244/EIJ-D-18-00603

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Lahmann A, Mankerious N, Xhepa E, Laugwitz K, Schunkert H, Fusaro M, Kastrati A, Joner M

June 20, 2018 | 10.4244/EIJ-D-18-00024

Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials

Cassese S, Byrne R, Jüni P, Wykrzykowska JJ, Puricel S, Ndrepepa G, Schunkert H, Fusaro M, Cook S, Kimura T, Henriques J, Serruys P, Windecker S, Kastrati A

January 19, 2018 | 10.4244/EIJ-D-17-00492

Parallel suture technique with ProGlide: a novel method for management of vascular access during transcatheter aortic valve implantation (TAVI)

Ott I, Shivaraju A, Schafer N, Frangieh A, Michel J, Husser O, Hengstenberg C, Mayr P, Colleran R, Pellegrini C, Cassese S, Fusaro M, Schunkert H, Kastrati A, Kasel AM

October 20, 2017 | 10.4244/EIJ-D-16-01036

Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Xhepa E, De Waha A, Rheude T, Colleran R, Giacoppo D, Harada Y, Laugwitz K, Schunkert H, Fusaro M, Kastrati A

October 20, 2017 | 10.4244/EIJ-D-16-00871

Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis

Cassese S, Ndrepepa G, Kufner S, Byrne R, Giacoppo D, Ott I, Laugwitz K, Schunkert H, Kastrati A, Fusaro M

July 20, 2017 | 10.4244/EIJ-D-16-00735

Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry

Wiebe J, Hoppmann P, Kufner S, Harada Y, Colleran R, Michel J, Giacoppo D, Schneider S, Cassese S, Ibrahim T, Schunkert H, Laugwitz K, Kastrati A, Byrne R

June 10, 2016 | 10.4244/EIJY16M05_03

Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial

Kufner S, Byrne R, Valeskini M, Schulz S, Ibrahim T, Hoppmann P, Schneider S, Laugwitz K, Schunkert H, Kastrati A

March 18, 2016 | 10.4244/EIJY14M11_02

Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention

Fiedler A, Ndrepepa G, Schulz S, Floh S, Hoppmann P, Kufner S, Bernlochner I, Byrne R, Schunkert H, Laugwitz K, Kastrati A

February 12, 2016 | 10.4244/EIJV11I11A249

First use of an expandable sheath and transcaval access for transcatheter Edwards SAPIEN 3 aortic valve implantation

Ott I, Greenbaum A, Schunkert H, Kastrati A, Kasel AM

November 20, 2015 | 10.4244/EIJY15M05_08

Tools and Techniques - Clinical: Fluoroscopic balloon sizing of the aortic annulus before transcatheter aortic valve replacement (TAVR) – follow the “right cusp rule”

Shivaraju A, Thilo C, Ott I, Mayr P, Schunkert H, von Scheidt W, Thoenes M, Byrne R, Kastrati A, Kasel AM

November 20, 2015 | 10.4244/EIJV11I7A170

Bivalirudin versus heparin in patients treated with percutaneous coronary intervention: a meta-analysis of randomised trials

Cassese S, Byrne R, Laugwitz K, Schunkert H, Berger P, Kastrati A

June 19, 2015 | 10.4244/EIJY14M08_01

Heribert Schunkert

Latest news